Study to Compare Contrast-Enhanced Ultrasound, Contrast-Enhanced Dual Energy Mammography, and Contrast-Enhanced Breast MR for Early Breast Cancer Detection

Overview

About this study

The purpose of this study is to determine whether contrast-enhanced ultrasound (CEUS) can be used in diagnostic evaluation of breast lesions that cannot be seen using contrast-enhanced MRI (CEMR) and contrast- enhanced dual energy mammography (CEDM). If so, patients can undergo US guided biopsy which is more comfortable for patients and more cost effective.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Provision of signed and dated informed consent form.
Stated willingness to comply with all study procedures and availability for the duration of the study.
Patients, greater than 30 years of age.
In good general health as evidenced by medical history.
BIRADS 4 or 5 suspicious breast lesions who are scheduled for breast biopsy.

Exclusion Criteria:

Patients who are less than 30 years of age.
Have known or suspected cardiac shunts.
Have history of hypersensitive allergic reactions to any imaging contrast agents.
Pregnant (a urine pregnancy test will be given at no cost to the patient).
Are nursing babies.
Poor renal function.
Are unwilling or unable (such as having a pacemaker) to undergo a CEMR.

More information

Publications

Publications are currently not available

Clinical Trials